logo
logo
Sign in

ESMO 2019: Seven promising digital health intervention companies participating in ESMO

avatar
Jacob Logan
ESMO 2019: Seven promising digital health intervention companies participating in ESMO

Two of the company’s key products include the CARDIOSKIN™ and ON’COHUB™.

CARDIOSKIN™is an ECG solution that helps in long-term monitoring and data analysis for patients with various indications, including syncope, palpitations, atrial fibrillation, coronary ischemia, dilated cardiomyopathy, hypertrophic cardiomyopathy, and inherited arrhythmic diseases.

ON’COHUB™ is an e-solution designed to provide follow-up data collection and management in patients with solid tumours.

Founded in 2012 at Aalto University, Finland, the company offers personalised support to cancer patients through various phases of therapy by providing self-management strategies and digital symptom management, as well as reduce emergency room visits through its platform.

Despite the lack of knowledge on adverse events in cancer immunotherapies, Kaiku Health is working towards understanding and managing toxicities of immune checkpoint inhibitor and CAR T Cell therapies.

The OncoBEAM™ is a digital polymerase chain reaction (PCR) technology that combines emulsion PCR and flow cytometry for the detection of mutant tumour DNA molecules.

collect
0
avatar
Jacob Logan
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more